A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

  • STATUS
    Recruiting
  • participants needed
    16
  • sponsor
    Memorial Sloan Kettering Cancer Center
Updated on 30 March 2023
cancer
primary brain tumors

Summary

The purpose of this study is to test if PET scans using 89Zr-DFO-cRGDY-PEG-Cy5-C' dot particles, can be used to take pictures of brain tumors. The investigators want to understand how the particles are distributed and removed from the body, which may help others be treated in the future. This will be the first time that 89Zr-DFO-cRGDY-PEG-Cy5-C' dot particles are being used in people. The amount of particles given in this study is very small compared to the amount that was used in mice animal studies.

Details
Condition Brain Cancer, Pituitary Adenoma
Treatment blood and urine samples, 89Zr-DFO-cRGDY-PEG-Cy5-C' dots PET/CT Imaging, 89Zr-DFO-cRGDY-PEG-Cy5-C' dots PET Imaging
Clinical Study IdentifierNCT03465618
SponsorMemorial Sloan Kettering Cancer Center
Last Modified on30 March 2023

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note